High Purity Pharma Raw Material Aniracetam for Cognition Enhancer


GABA Nootropics Nefiracetam
High Purity Pharma Raw Material Aniracetam for Cognition Enhancer (72432-10-1)

Aniracetam powder
Aniracetam powder

Aniracetam Synonyms: 1-(4-methoxybenzoyl)-2-pyrrolidinon;1-(p-methoxybenzoyl)-2-pyrrolidinon;1-p-anisoyl-2-pyrrolidinone;draganon;sarpul;1-(4-METHOXYBENZOYL)-2-PYRROLIDINONE;ANIRACETAM;RO 13-5057
Aniracetam CAS: 72432-10-1
Aniracetam MF: C12H13NO3
Aniracetam MW: 219.24
Aniracetam Chemical Properties Crystalline Solid
Aniracetam Usage cognitive enhancer
Aniracetam Usage Cognition enhancer related to Piracetam. Nootropic.
Biological Activity Nootropic, with modulatory actions through allosteric potentiation of AMPA specific receptors, reduction of glutamate receptor desensitization and potentiation of metabotropic glutamate receptor activity. Anxiolytic following systemic administration.
Aniracetam are related to improved mental performance. This includes an increase in memory and possibly
Even enhanced learning capacity. This may actually occur differently in each person; Some will see strong
Effects and begin remembering everything while others may just simply begin remembering small and subtle
Details. Aniracetam is also considered be very helpful as a focusing agent. Many users note that their attention
Span is increased as well as being able to focus and concentrate much more easily. This also serves to
Improve mental fluidity, making even simple, routine tasks such as reading and writing (and holding
Conversations) seem to flow much more easily, without expending as much effort as before using Aniracetam
L Improving Memory
L Improving the brain function
L Preventing and treating senile demential
Enhancing the learning ability
L Increasing the attention
L Relieving the anxiety

Aniracetam is anampakine nootropic of the racetam chemical class purported to be considerably more potent than piracetam. It is lipid-soluble and has possible cognition-enhancing effects. It has been tested in animals extensively, Alzheimer’s patients, and temporarily impaired healthy subjects.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s